l carnitine tmao conversion γ–Butyrobetaine is a pro-atherogenic intermediate in gut microbial metabolism of L-carnitine to Carnitine - Metabolite of the
Carnitine Metabolite of the month biocrates life sciences gmbh Frontiers The microbial metabolite trimethylamine N oxide and the kidney diseases Frontiers Gut Microbiota Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target The Gut Arterial Stiffness Axis: Is TMAO a Novel Target to Prevent Age Related Aortic Stiffening? Hypertension JCI l Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans
Pay in 4 interest-free payments of $7.31 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 29 - Nov 3




